Another study stated that combination of psoralidin and neobavaisoflavone with TNF-related apoptosis-inducing ligand (TRAIL) has highlighted their anticancer activity through inducing apoptosis in human adenocarcinoma prostate cancer cells [84, 87]. Here, TNFSF10 is linked to prostate cancer.